CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 46 enrolled
Drug / intervention
Optimel Antibacterial Manuka+ Dry Eye Drops +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03622619
NCT03622619N/ACompleted
CompareCT.gov

The Effect of Manuka Eye Drops on Tear Film Properties

The University of New South Wales·interventional·Posted Aug 9, 2018·Updated May 18, 2021

In Brief

A clinical study evaluating Optimel Antibacterial Manuka+ Dry Eye Drops and Systane Ultra Lubricating Eye Drops for Dry Eye Syndrome. Completed, enrolled 46 participants across 1 site.

Detailed Summary

Traditionally, Manuka honey has been used to combat against bacteria and reduce inflammation (the body's way of reacting to infection, irritation or other injury). Due to the inflammatory nature of dry eye, Manuka eye drops show promise as a treatment for dry eye disease. The aim of this research is to compare the effects of two over the counter eye drops that are used to treat dry eye conditions over a one month period.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDry Eye Syndrome
CountriesAustralia
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedAug 9, 2018
Enrollment StartAug 13, 2018
Primary CompletionOct 30, 2018
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 7.9 years ago

Interventions

Optimel Antibacterial Manuka+ Dry Eye Dropsother

Leptospermum sp Honey 165mg/g

Systane Ultra Lubricating Eye Dropsother

Polyethylene glycol 400 0.4% and propylene glycol 0.3%